Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Lymphoma 54Lymphoma, Large B-Cell, Diffuse 49Lymphoma, Non-Hodgkin 48Lymphoma, Mantle-Cell 37Lymphoma, Follicular 32Hodgkin Disease 28Lymphoma, Large-Cell, Immunoblastic 23Burkitt Lymphoma 22Leukemia, Lymphocytic, Chronic, B-Cell 21Glioblastoma 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Multiple Myeloma 17Lymphoma, B-Cell, Marginal Zone 15Gliosarcoma 15Brain Neoplasms 15Central Nervous System Neoplasms 14Neoplasms, Plasma Cell 11Glioma 11Astrocytoma 11Leukemia 10Lymphoma, B-Cell 9Recurrence 7Lymphoma, T-Cell 7Waldenstrom Macroglobulinemia 5Oligodendroglioma 5Lymphoma, T-Cell, Peripheral 5Lymphoma, T-Cell, Cutaneous 4Lymphoma, Large-Cell, Anaplastic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Acute 4

Interventions

Surveys and Questionnaires 114Exercise 103Blood Specimen Collection 99Radiotherapy 67Gemcitabine 64Bevacizumab 57Standard of Care 56Cisplatin 55Cyclophosphamide 51Capecitabine 50Carboplatin 49Docetaxel 47pembrolizumab 46Dexamethasone 46Paclitaxel 45Interviews as Topic 43Oxaliplatin 40Magnetic Resonance Spectroscopy 39Fluorouracil 37Methods 36Irinotecan 36Therapeutics 33Drug Therapy 33Radiosurgery 31Nivolumab 30Erlotinib Hydrochloride 27Educational Status 26Everolimus 24Leucovorin 23Control Groups 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Neoplasms × Carmustine × Clear all
NCT02366663 2018-03-12

SPINOZA

City of Hope Medical Center

Phase 3 Terminated
3 enrolled 8 charts
Lymphoid

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT00083551 2015-11-23

UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy

University of Arkansas

Phase 3 Completed
668 enrolled 7 charts
Plasma cell

Multiple Myeloma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡